What is the appropriate approach for a breast case sheet, including diagnosis and treatment options for breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comprehensive Approach to Breast Cancer Case Sheet Management

The appropriate approach for a breast cancer case sheet requires standardized documentation of diagnosis, staging, and treatment planning through a multidisciplinary team in specialized breast units, with detailed pathological assessment including biomarkers to guide personalized treatment decisions. 1

Diagnostic Documentation Requirements

  • Diagnosis should be based on clinical examination, imaging (bilateral mammography and ultrasound), and pathological assessment via core needle biopsy 1
  • Pathological report must include histological type, grade, ER/PgR status, HER2 status, and proliferation markers such as Ki67 1
  • Document complete personal and family medical history, menopausal status, physical examination findings, and laboratory results (full blood count, liver and renal function tests, alkaline phosphatase, calcium) 1
  • For higher-risk disease (≥4 positive nodes, T4 tumors), document results of additional staging investigations (chest X-ray, abdominal ultrasound, bone scan) 1
  • Consider MRI in specific cases: BRCA mutations, breast implants, lobular cancers, suspected multifocality/multicentricity, or before neoadjuvant chemotherapy 1

Staging and Risk Assessment Documentation

  • Document TNM staging (clinical pre-treatment and pathological post-surgery) 1
  • Record risk stratification based on tumor burden/location and biology 1
  • Document axillary lymph node status based on clinical examination, ultrasound, and biopsy of suspicious nodes 1
  • For bilateral disease, each breast cancer should be staged independently 2
  • Include validated gene expression profiles when used for prognostic/predictive information 1

Treatment Plan Documentation

  • Document multidisciplinary team discussion and decisions 1
  • Record surgical approach (breast-conserving surgery with radiation or mastectomy) with rationale 1
  • Document axillary management strategy (sentinel node biopsy or axillary dissection) 1
  • For systemic therapy, record:
    • Endocrine therapy plan for hormone receptor-positive tumors 1, 2
    • Anti-HER2 therapy plus chemotherapy for HER2-positive tumors 2, 3
    • Chemotherapy regimen for triple-negative or high-risk tumors 2, 4
  • Document radiation therapy plan, including fields, dose, and schedule 1
  • Record sequence of therapies (neoadjuvant vs. adjuvant approach) 1

Special Situations Documentation

  • For ductal carcinoma in situ (DCIS), document management approach (breast-conserving surgery with radiation or mastectomy, with or without tamoxifen) 1
  • For bilateral breast cancer with different pathologies, document individual treatment plans for each breast 2
  • For patients with ptosis, document oncoplastic surgical approach or reconstruction plans 5
  • For hereditary breast cancer, document genetic counseling and testing recommendations 1

Follow-up Plan Documentation

  • Record recommended follow-up schedule: every 3-4 months in first 2 years, every 6 months from years 3-5, annually thereafter 1
  • Document plan for annual ipsilateral/contralateral mammography with ultrasound 1
  • Record recommendations for lifestyle modifications (regular exercise, weight management) 1
  • Document access to rehabilitation services for physical and psychological support 1, 5

Common Pitfalls to Avoid

  • Incomplete biomarker testing can significantly impact treatment decisions; ensure all required markers (ER, PgR, HER2, Ki67) are documented 1
  • Failure to document multidisciplinary discussion may lead to fragmented care 1
  • Inadequate staging can result in inappropriate treatment selection; ensure proper documentation of all staging procedures 1
  • Lack of documentation regarding patient preferences and involvement in decision-making 1
  • Insufficient documentation of treatment rationale, especially when deviating from standard guidelines 1

By following this comprehensive approach to breast cancer case sheet documentation, healthcare providers can ensure standardized, high-quality care for breast cancer patients while facilitating effective communication among the multidisciplinary team.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Protocol for Bilateral Breast Cancer with Different Pathologic Biopsy Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Breast Ptosis in Breast Cancer Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.